Latest Articles

Publication Date
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval - Labiotech.eu

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Labiotech.eu

Published: April 23, 2025, 1:01 p.m.
Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance - RadarOnline

Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance RadarOnline

Published: April 22, 2025, 3:23 p.m.
Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance - radaronline.com

Hailey Bieber Reveals Her 'Shocking' Health Condition Has RETURNED Amid Husband Justin's Latest Worrying Behavior During Drug-Fueled Coachella Appearance radaronline.com

Published: April 22, 2025, 3:23 p.m.
‘the endometriosis pay gap costs women £130 every month – i should know’ - Readly | All magazines - one magazine app subscription

‘the endometriosis pay gap costs women £130 every month – i should know’ Readly | All magazines - one magazine app subscription

Published: April 22, 2025, 3:35 a.m.
4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work - Hindustan Times

4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work Hindustan Times

Published: April 21, 2025, 1:38 p.m.
Pearsanta to begin study of endometriosis test with IRB approval - MSN

Pearsanta to begin study of endometriosis test with IRB approval MSN

Published: April 19, 2025, 1:06 a.m.
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
‘Incredibly disappointing’: Period pain education program scrapped - The Mercury

‘Incredibly disappointing’: Period pain education program scrapped The Mercury

Published: April 18, 2025, 7:05 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!